Moderna (NASDAQ: $MRNA) posted its fourth-quarter results on Friday, February 14, 2025, beating revenue estimates. However, losses came in higher than expected, causing the stock […]
Tag: MRNA
Moderna, Inc. (NASDAQ: $MRNA): Is the Biotech Giant Still a Buy in 2024 After COVID-19 Vaccine Success?
Moderna, Inc. (NASDAQ: $MRNA) has come a long way since its early days as a relatively unknown biotech company. Founded in 2010, the Cambridge, Massachusetts-based […]